Research progress on the protection and mechanism of active peptides in Alzheimer's disease and Parkinson's disease

被引:0
|
作者
Ding, Xuying [1 ]
Chen, Yutong [1 ]
Zhang, Xiaojun [2 ]
Duan, Yanming [1 ]
Yuan, Guojing [1 ]
Liu, Chang [1 ]
机构
[1] Beihua Univ, Coll Pharm, Jilin 132013, Jilin, Peoples R China
[2] Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China
关键词
AD; PD; active peptide; neuron; oxidative stress; mitochondrial damage; MILD COGNITIVE IMPAIRMENT; BLOOD-BRAIN-BARRIER; OXIDATIVE STRESS; MEMORY; BEHAVIOR; MICE;
D O I
10.1016/j.npep.2024.102457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurodegenerative diseases are the main causes of death and morbidity among elderly people worldwide. From the pathological point of view, oxidative stress, neuroinflammation, mitochondrial damage and apoptosis are the causes of neuronal diseases, and play a harmful role in the process of neuronal cell death and neurodegeneration. The most common neurodegenerative diseases are Alzheimer's disease(AD) and Parkinson's disease(PD), and there is no effective treatment. The physiological role of active peptides in the human body is significant. Modern medical research has found that animal and plant peptides, natural peptides in human body, can act on the central nervous system, and their active components can improve learning and memory ability, and play the roles of antioxidation, anti-inflammation, anti-apoptosis and maintaining the structure and function of mitochondria. This review reviews the reports on neurodegenerative diseases such as AD and PD by active peptides from animals and plants and natural peptides from the human body, and summarizes the neuroprotective mechanism of peptides. A theoretical basis for further research and development of active peptides was provided by examining the research and application of peptides, which provided a theoretical basis for further research and development.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The Mechanism of Disease of Alzheimer's and Parkinson Disease
    De Groen, Piet
    [J]. NEUROLOGY, 2023, 100 (17)
  • [2] Research Progress on the Mechanism of NMDA Receptor in Parkinson's Disease
    Liu, Heng
    Liu, Min
    Zhang, Shanshan
    Li, Wenwen
    Wang, Aimin
    Yang, Fuguo
    Jiang, Hong
    [J]. PANMINERVA MEDICA, 2020,
  • [3] Research Progress in Pathophysiological Mechanism of Dyskinesia in Parkinson's Disease
    Zhong, Zhe
    Xu, Min
    Yang, Lan Qing
    Chen, W. J.
    Gao, Huan
    Ye, Min
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 83 : 139 - 143
  • [4] Translational research in Alzheimer's disease and Parkinson's disease.
    Schmechel, Don
    [J]. NEUROTOXICOLOGY, 2006, 27 (06) : 1157 - 1157
  • [5] Active Immunotherapy for the Prevention of Alzheimer's and Parkinson's Disease
    Vroom, Madeline M.
    Dodart, Jean-Cosme
    [J]. VACCINES, 2024, 12 (09)
  • [6] Progress in the research and neurotherapeutics for Parkinson's disease
    Hattori, N
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 50P - 50P
  • [7] Research Progress of Pyroptosis in Alzheimer's Disease
    Xue, Weiyue
    Cui, Di
    Qiu, Ye
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [8] Research Progress on Alzheimer's Disease and Resveratrol
    Yan, Yan
    Yang, Huihuang
    Xie, Yuxun
    Ding, Yuanlin
    Kong, Danli
    Yu, Haibing
    [J]. NEUROCHEMICAL RESEARCH, 2020, 45 (05) : 989 - 1006
  • [9] Research Progress of Mitophagy in Alzheimer's Disease
    Yao, Jinglin
    Kan, Bohong
    Dong, Zhengjia
    Tang, Zhenyu
    [J]. CURRENT ALZHEIMER RESEARCH, 2023, 20 (12) : 827 - 844
  • [10] Research Progress on Alzheimer's Disease and Resveratrol
    Yan Yan
    Huihuang Yang
    Yuxun Xie
    Yuanlin Ding
    Danli Kong
    Haibing Yu
    [J]. Neurochemical Research, 2020, 45 : 989 - 1006